This toolbox was developed for the World Health Organisation COVID-19 Research Roadmap as a joint initiative between the social science and ethics working groups. 

Good Participatory Practice Guidelines for Emerging Pathogens (GPP-EP) help ensure respectful community engagement and strengthen trust through collaborative partnerships. GPP-EP applies across research types and settings, and at all stages of research.

This document is based on GPP-EP guidelines that were prepared by Dr Catherine Hankins for the World Health Organization in December 2016, and is a synthesis of key action points. This “how to” guide, overview, tips and resources will be updated as new resources are completed and approved.

Download the GPP in COVID-19 Clinical Trials toolbox [PDF] HERE

This article is part of our theme area on Good Participatory Practice in COVID-19 Research 

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License

Also By

Mesh Editorial Team

Categories

GPP- Guidelines (Mesh)  Epidemics (Mesh)  Participatory Research (mesh)  Trial Design (Mesh)  Trial Design (Mesh-Guides)  Trial Conduct (Mesh)  Trial Conduct (Mesh-Guides)  Epidemics - programme design (Mesh)  Epidemics - programme design - biomedical (Mesh)  Epidemics - implementation (Mesh)  Epidemics - implementation - during (Mesh)  Epidemics - implementation - during - biomedical (Mesh)  Epidemics - implementation - post (Mesh)  Epidemics - implementation - post - biomedical (Mesh)  Epidemics - general resources (Mesh)  Epidemics - general CE resources (Mesh)  COVID-19 (Mesh)  GPP - Lifecycle All (Mesh)  GPP - Lifecycle Study Design (Mesh)  GPP - Lifecycle Before (Mesh)  GPP - Lifecycle During (Mesh)  GPP - Lifecycle After (Mesh)  

Tags

Reply

Please Sign in (or Register) to view further.